GaBI Journal is circulated to healthcare professionals involved in all aspects of medicinal provision including:

• physicians
• pharmacists
• healthcare providers, e.g. nurses, scientists, hospital directors
• regulatory agencies (national and international)
• national pricing and reimbursement authorities, health technology assessment boards, healthcare purchasers
• policymakers, policy advisers, politicians
• insurance companies, healthcare payers
• members of relevant societies such as FIP, IAPO (patient group)

The initial circulation exceeds 5,000 copies targeting professionals in clinical practice and healthcare policies, pharmaceutical experts and scientists worldwide.

Subscribers include:

• generics/biosimilars/innovator pharmaceutical companies
• biotechnology companies
• manufacturers of chemicals/raw materials (API)
• industry suppliers
• clinical research and manufacturing organisations

For print and online (website) circulation details, request here.